Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160.
about
Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertasesIsolation of the human PC6 gene encoding the putative host protease for HIV-1 gp160 processing in CD4+ T lymphocytesThe role of eukaryotic subtilisin-like endoproteases for the activation of human immunodeficiency virus glycoproteins in natural host cellsStructural and functional analysis of interhelical interactions in the human immunodeficiency virus type 1 gp41 envelope glycoprotein by alanine-scanning mutagenesis.Synthesis, assembly, and processing of the Env ERVWE1/syncytin human endogenous retroviral envelope.CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infectionCharacterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41C-terminal tail of human immunodeficiency virus gp41: functionally rich and structurally enigmatic.Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1Novel human endogenous sequences related to human immunodeficiency virus type 1.Affinity maturation by targeted diversification of the CDR-H2 loop of a monoclonal Fab derived from a synthetic naïve human antibody library and directed against the internal trimeric coiled-coil of gp41 yields a set of Fabs with improved HIV-1 neutEndoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function.Functional chimeras of human immunodeficiency virus type 1 Gp120 and influenza A virus (H3) hemagglutininEfficient infection mediated by viral receptors incorporated into retroviral particles.Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env incorporation into virionsReversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity.Identification and characterization of fusion and processing domains of the human immunodeficiency virus type 2 envelope glycoprotein.Mutation-directed chemical cross-linking of human immunodeficiency virus type 1 gp41 oligomers.GPI-anchored single chain Fv--an effective way to capture transiently-exposed neutralization epitopes on HIV-1 envelope spike.Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins.Cytoplasmic tail of Moloney murine leukemia virus envelope protein influences the conformation of the extracellular domain: implications for mechanism of action of the R Peptide.Interplay between HIV entry and transportin-SR2 dependencyHuman Ubc9 is involved in intracellular HIV-1 Env stability after trafficking out of the trans-Golgi network in a Gag dependent manner.Different infectivity of HIV-1 strains is linked to number of envelope trimers required for entryHIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation.Potent and broad anti-HIV-1 activity exhibited by a glycosyl-phosphatidylinositol-anchored peptide derived from the CDR H3 of broadly neutralizing antibody PG16.Effects of second-site mutations on dominant interference by a human immunodeficiency virus type 1 envelope glycoprotein mutant.Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix.Mutations within a putative cysteine loop of the transmembrane protein of an attenuated immunodeficiency-inducing feline leukemia virus variant inhibit envelope protein processing.Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporationDomains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposureMultitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates.Retroviral env glycoprotein trafficking and incorporation into virions.Blockade of human immunodeficiency virus type 1 production in CD4+ T cells by an intracellular CD4 expressed under control of the viral long terminal repeat.Experimental Estimation of the Effects of All Amino-Acid Mutations to HIV's Envelope Protein on Viral Replication in Cell CultureStructure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs.
P2860
Q24534205-26A6CFA0-85BB-4118-9B81-CF242A6B70C2Q24621842-D7D898A8-EF06-4EF9-BB2A-34B27F5C5D3CQ24678833-3938C091-95CD-41F8-A300-B546B5FCEB57Q27635422-DB18C62C-6037-446B-86E6-80FC8A74510AQ28244876-45AE45A7-C0C9-429C-8C1A-97EDFA704BEEQ28542878-A71D1C32-492C-42B7-AC5F-70DFEBD745BDQ28646771-B7BB95D8-167D-4D17-82A9-8DAEB4F39BA7Q30422545-6ECA8E4C-FCD6-4123-A891-A91F1B275A96Q30447936-076368B5-6BA8-4BA1-9EF8-AEF9ED121327Q31121071-F3A4232C-816E-4F11-AFD3-B6A9C16498DFQ33495440-9BE69FA2-9CF5-46C3-A7FC-9602F01C278AQ33641497-F3D4C308-8278-468F-BC71-1E593610DB00Q33780529-52978506-5999-47B7-8C33-97DBF9E4AC5FQ33782125-CECD4221-2DC9-455B-B25E-B5A1FD0A6426Q33782781-742BBC02-09EA-4606-8CE1-7E44F0D4FD69Q33785977-4434BC28-9D0B-4270-AEDC-3ADD2E464DE4Q33805110-C88D37F3-0575-4E20-8927-AEB2DBAA43F2Q33813747-B79A9A18-BF5B-4EDB-B7A3-A15BFD548F2AQ33935988-A4C5944A-F2D1-47E3-9C0F-93D934D18DBFQ34070049-BFEA07E9-58E1-4B8D-B607-CD203395BEC7Q34221625-CFC6F457-6A93-4539-91F8-D4EB6BEA50E5Q34332728-6B56AC61-0AF6-4C4D-B711-FD002F629081Q34464572-EE2359DC-C1EC-4B3F-AD5B-1A2A77A1C780Q34586080-FE402449-B43C-4239-AB15-A1BCE622C465Q34828531-EE4685E4-DDED-47A4-AEAD-93E72A0CB059Q34875765-25D542F5-1F95-4860-9970-E3E923B0029BQ35113720-68DDD6FC-9206-4EBB-95FA-411B0311A1FFQ35192886-D2EA97D2-0ED9-45D9-86D0-89F382EC405AQ35833507-701FE498-E259-4D77-84F8-EEEE9EF35B67Q35835956-7346F12A-9D62-43DC-906F-5174D4C31669Q35837311-FBB9A86C-19DB-44A9-B3AF-3FD890F55984Q35844026-2A84AD2A-0553-42D2-A3E1-9E776882BC99Q35853659-941660B3-547D-4DCC-95FD-24F174B8B4B8Q35870903-2A059967-2DDB-43CB-9C3E-F52CF4DCAEEDQ35927204-43E54995-DBBB-4B63-9024-DD2D45167E3BQ36090433-53BC3BB0-4744-4262-AAA7-A4B333A5BC6EQ36193108-66BEA876-5240-487C-9F96-4082273C5F4CQ36222292-2A9609FF-4A77-4541-AB28-DBB1A2EA8E62Q36246403-9B4AB202-7D8C-4DD0-BD8F-3E2D934E828BQ36267348-52079647-B710-48C2-8F13-CE6337C48166
P2860
Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Mutational analysis of the cle ...... glycoprotein precursor gp160.
@en
type
label
Mutational analysis of the cle ...... glycoprotein precursor gp160.
@en
prefLabel
Mutational analysis of the cle ...... glycoprotein precursor gp160.
@en
P2093
P2860
P1433
P1476
Mutational analysis of the cle ...... glycoprotein precursor gp160.
@en
P2093
P2860
P304
P407
P577
1989-11-01T00:00:00Z